Cresco assisted Fibricheck in the negotiation of its app acceleration agreement with Samsung Electronics for integration of the FibriCheck app in Samsung smart phones and wearables (such as the Galaxy phone and watches).
FibriCheck’s mission is to make healthcare widely available, affordable and unlinked to time and location. Fibricheck targets the prevention of possibly life-threatening and disabling strokes by enabling early detection of heart rhythm disorders, with a main focus on atrial fibrillation (Afib). Fibricheck makes the detection of heart rhythm disorders possible with just a smartphone or smartwatch using the clinically validated PPG technology.
David Dessers and Olivier Van Raemdonck assisted Fibricheck in this transaction.
More information on this transaction can be found in De Tijd.